Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Trimethoprim

SKU: orb1224102

Description

Trimethoprim is a Dihydrofolate Reductase Inhibitor Antibacterial.(In Vitro):Trimethoprim interrupts folate metabolism by inhibition of the activity of dihydrofolase reductase (DHFR), which reduces dihydrofolate to tetrahydrofolate (THF).Trimethoprim (3 μg/mL; 1 h) induces protein aggregation and main heat shock proteins (Hsps) in E. coli cells, which indicates that Trimethoprim sulfate presence leads to protein misfolding.Trimethoprim (1.5-3 μg/mL; 1 h) causes induction of DnaK, DnaJ, GroEL, ClpB, and IbpA/B Hsps in E. coli cells exposed to folate and heat stress.(In Vivo):Trimethoprim (10 mg/kg; i.v.; once every 12 h; 3 d) shows antibacterial activity against H. influenzae, S. pneumoniae, E. coli and N. meningitidis in infected mice.Trimethoprim can be connected with the thiomaltose (TM-TMP) and shows stability with a half-life of about 1 hour in complete serum, and has an MIC value around 1 μM against E. coli.Trimethoprim (10 mg/mL; 0.5 mL; inject with Trimethoprim-Zn combined suspension) decreases the virus titer and increases the survival rate of chicken embryo.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number738-70-5
MW290.32
Purity>98% (HPLC)
FormulaC14H18N4O3
SMILESNC1=NC=C(CC2=CC(OC)=C(OC)C(OC)=C2)C(N)=N1
TargetDHFR
SolubilityDMSO: 58 mg/mL (199.77 mM)

Bioactivity

In Vivo
Animal model: Female C3H/HeOuJ mice (transurethrally infected with a 50 μL suspension containing 1-2×107 CFU of E. coli under 3% isoflurane). Dosage: 10 mg/kg. Administration: i. v. ; once every 12 h; for 3 d. Result: Showed antibacterial activity against H. influenzae, S. pneumoniae, E. coli and N. meningitidis with CD50s of 150 mg/kg, 335 mg/kg, 27.5 mg/kg and 8.4 mg/kg, respectively in infected mice. Animal model: Fertilized eggs (injected H3N2 virus into amniotic and allantoic space at day 8). Dosage: 10 mg/mL; 0.5 mL. Administration: The Trimethoprim-Zn combined suspension was injected into the air sac; single dosage. Result: Decreased the virus titer and increased the survival rate of chicken embryo. The survival rate peaked at ratio about 0.18 (Zn/Trimethoprim).

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

NIH 204 | NSC 106568

Similar Products

  • Trimethoprim sulfate [orb1740391]

    56585-33-2

    678.72

    C28H38N8O10S

    50 mg, 100 mg, 25 mg
  • Trimethoprim [orb1309588]

    99.80% (May vary between batches)

    738-70-5

    290.32

    C14H18N4O3

    500 mg
  • Sulfamethoxazole sodium [orb1299186]

    99.13% (May vary between batches)

    4563-84-2

    275.26

    C10H10N3NaO3S

    500 mg, 1 g, 1 ml x 10 mM (in DMSO), 5 g, 50 mg, 100 mg, 10 g
  • Trimethoprim lactate [orb1691000]

    99.90% (May vary between batches)

    23256-42-0

    380.4

    C17H24N4O6

    200 mg, 1 ml x 10 mM (in DMSO), 500 mg
  • Trimosulfa [orb1702713]

    99.93% (May vary between batches)

    8064-90-2

    543.6

    C24H29N7O6S

    50 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information